ORGANIC VACCINES Plc is a life sciences company dedicated to deliver novel personalized therapies, novel vaccines and novel molecular adjuvants.
Organic Vaccines focus is on:- Immune system preservation and restoration through White Blood Cells Banking
HIVax, its new vaccine against HIV-1, has completed Phase IIa studies. Among many vaccine attempts, only the HIVax vaccine was able to show tangible phase II results in controlling the viral rebounds after cART interruption and rendering HIV DNA undetectable. With a 3-year perspective, some (undisclosed) patients may show signs of retro-seroconversion.